drugset / Trial / NCT01117623
Continuous Dosing of BAY73-4506 in Patients With Advanced Malignancies
Non-randomizedParallel-groupOpen-label
Summary
Continuous dosing of BAY73-4506 in patients with advanced cancer
Timeline
- Start
- 2007-02
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Regorafenib | Small molecule | 20 mg | Oral |
| Subject | Regorafenib | Small molecule | 40 mg | Oral |
| Subject | Regorafenib | Small molecule | 100 mg | Oral |
| Subject | Regorafenib | Small molecule | 120 mg | Oral |
| Subject | Regorafenib | Small molecule | 140 mg | Oral |